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ADH = atypical ductal hyperplasia; ALH = atypical lobular hyperplasia; DCIS = ductal carcinoma in situ; FNAC = fine needle aspiration cytology;
LCIS = lobular carcinoma in situ; VAM = vacuum assisted mammotomy.
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Introduction
Mammography is the primary imaging tool for the detec-
tion and diagnosis of ductal carcinoma in situ (DCIS).
Other imaging techniques such as ultrasound, magnetic
resonance imaging and scintimammography are insensi-
tive in the absence of an invasive focus. Microcalcification
is the commonest mammographic feature of DCIS and is
seen in 80–90% of those cases with a mammographic
abnormality [1]. However, the chance of symptomatic
DCIS having a mammographic abnormality varies accord-
ing to the clinical presentation. Virtually all cases of DCIS
presenting with single duct nipple discharge have a mam-
mographic abnormality, whereas only 50% of women with
DCIS presenting as Paget’s disease of the nipple have a
mammographic abnormality [2].
Approximately 80% of cases of calcific DCIS have an
irregular cluster shape and about 10% of these irregular
clusters are ‘V’ shaped. The irregular cluster shape of
DCIS is caused by the growth pattern of DCIS, which
has a tendency to grow toward and away from the
nipple within a single segment of the breast. One of the
commonest and most characteristic features of DCIS is
that the calcifications are aligned in a ductal distribu-
tion. This distribution is common in both necrotic and
non-necrotic DCIS. If calcifications lack rod or branch-
ing shapes, then a ductal distribution can be extremely
helpful in suggesting the presence of DCIS. Approxi-
mately 90% of DCIS calcification clusters have more
than 10 flecks of calcification. However, diagnosing
DCIS is not uncommon in lesions with clusters of five
flecks or less.
The most common morphological features of calcifications
due to DCIS are granular calcifications with irregularity in
density, shape and size as compared with the other calcifi-
cations within the cluster. Although these features are
present in over 90% of cases of DCIS, their usefulness in
benign versus malignant differentiation is limited because
these features are also commonly found in benign causes
of calcification. The more specific features of DCIS such
as a ductal distribution of calcifications, and rod and
branching shapes are much less common, being found in
70%, 70% and 40% of cases, respectively. Punctate
(round or oval) calcifications are also commonly found in
DCIS. Just under 50% of DCIS calcification clusters
contain punctate calcifications and 15% have predomi-
nantly punctate calcifications [3].
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Pre-invasive disease is most frequently diagnosed in asymptomatic women following detection of
microcalcification at mammography. The vast majority is ductal carcinoma in situ. This article
summarizes the radiological features of pre-invasive disease and indicates which features are helpful in
differentiating between benign and malignant conditions. The value of finding ductal carcinoma in situ
at screening, predicting the presence of an invasive focus and methods of percutaneous biopsy of
calcification are also addressed.
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A recent study [4] that examined previous mammograms
of women with DCIS showed that in 22% the previous
mammograms were, in retrospect, abnormal. The calcifica-
tion morphology of the DCIS present on the previous
mammograms was much less characteristic of malignancy
than those present at the time of diagnosis. These cases,
which had such nonspecific features at the time of previ-
ous mammography, were predominantly high-grade DCIS.
This indicates that the characteristic morphological fea-
tures of the calcifications in high-grade DCIS are fre-
quently not present when the lesions are small.
In one recent study [5], by assessing and measuring mam-
mographic calcification due to DCIS that was missed on
previous mammography, the investigators were able to
gain information concerning DCIS growth rates and
growth directions. This study found that DCIS grows
twice as fast in the nipple plane as in the plane at 90° to
this. However, DCIS appears to grow at equal rates
toward and away from the nipple. There appears to be a
good correlation between both growth in the nipple plane
and at 90° to the nipple with the cytonuclear grade of
DCIS.
Atypical ductal hyperplasia (ADH), lobular carcinoma in situ
(LCIS) and atypical lobular hyperplasia (ALH) can all mani-
fest as mammographic calcification. They normally exhibit
high-density, clustered punctate calcification and tend to
lack the characteristic mammographic features of DCIS
such a rod shapes, a ductal distribution and branching.
Appearance of ductal carcinoma in situ
according to pathological subtype
The radiological appearances of DCIS vary markedly
according to the pathological subtype. The following patho-
logical variables have been shown to correlate with varia-
tions in the radiological appearance of DCIS: architectural
pattern, cell size, necrosis, C-ebB-2 expression, P53
expression, MIB-1, and oestrogen receptor and proges-
terone receptor expression. Holland and coworkers [6]
found that 80% of comedo DCIS had linear calcification but
this finding was only present in 16% of cribriform/micropap-
illary DCIS. That study also found that only 53% of the crib-
riform DCIS group had mammographic calcification, as
compared with 94% of the comedo group. In addition, the
report shows that mammographic estimation of DCIS lesion
size was more accurate in comedo DCIS than in the cribri-
form DCIS. Although other authors have confirmed that
linear calcifications are more common in the comedo
subtype of DCIS and that granular calcifications are more
common in the cribriform/micropapillary types, it is impossi-
ble to predict reliably the architectural pattern of DCIS on
mammography.
There are strong correlations between the presence or
absence of necrosis and the mammographic features of
DCIS. DCIS containing necrosis is more likely to show
abnormal mammographic findings, calcification, calcifica-
tion with a ductal distribution and rod shaped calcifica-
tions. DCIS without necrosis is more likely to show normal
mammography, a noncalcific mass, or predominantly
punctate calcification [1].
Post-conservation surveillance
Post-conservation surveillance mammography is especially
important in women who have undergone wide local exci-
sion for treatment of DCIS because at least 50% of
women with recurrent DCIS have invasive disease. Mam-
mography is the sole method for detecting recurrent DCIS
in the vast majority of these cases. A recent study of the
mammographic features of locally recurrent DCIS demon-
strated that 85% of local recurrences were detected
solely by mammography and that 95% of recurrent DCIS
was visible mammographically [7].
What is the value of detecting ductal carcinoma
in situ at mammographic screening?
The introduction of mammographic screening has led to a
dramatic increase in the number of cases of pure DCIS
diagnosed. Of screen-detected breast cancers 25% are
DCIS, as compared with 5% of symptomatic breast
cancer [8,9]. Screening of women who are under 50 years
of age identifies even higher proportions of DCIS lesions
than are seen when screening women older than 50 years
[10]. Critics of breast screening often claim that the high
rates of DCIS seen represent over-diagnosis, many being
lesions that would never present clinically and threaten the
woman’s life. This is compounded by the fact that such
lesions may be extensive and therefore frequently require
mastectomy to obtain adequate excision. Such criticism
would be valid if screen-detected DCIS lesions were pre-
dominantly of low histological grade. However, DCIS
detected by mammographic screening is predominantly of
high nuclear grade and only 13% is low grade [11].
Screen-detected DCIS is also more likely to contain areas
of necrosis than are symptomatic lesions.
The detection of high-grade DCIS by screening is likely to
prevent the development of high-grade invasive cancer
within a few years and could be important in producing
part of the mortality reduction seen in randomized trials of
mammographic screening. Approximately one-third of
malignant calcification clusters contain an invasive focus.
Recalling DCIS at screening is a good method of detect-
ing small invasive cancers. Features that predict the pres-
ence of an invasive focus within DCIS are DCIS of high
grade on core histology and increasing number of calcifi-
cations on mammography. High-grade DCIS on core and
more than 40 calcifications on mammography indicates a
48% chance of occult invasion, whereas high-grade DCIS
on core and fewer than 40 calcifications indicates a 15%
risk for invasion. Lesions with non-high-grade DCIS on252
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core biopsy carry a very low risk for occult invasion [12].
There is a strong correlation between screening unit DCIS
detection rates and their small invasive cancer detection
rates [13]. The increased availability of stereotactic core
biopsy with digital imaging should mean that an aggres-
sive approach to mammographic calcification should not
give rise to high rates of surgical benign biopsy [14].
ADH is a rare condition, being seen in only 4% of sympto-
matic benign biopsies. The incidence increases in associ-
ation with screen-detected benign microcalcifications. The
ability of mammography to detect microcalcification has
thus resulted in an increase in the detection of ADH.
Percutaneous biopsy of pre-invasive disease
Microcalcifications are particularly difficult to biopsy as
compared with mass lesions. This is true both for core
biopsy and for fine needle aspiration cytology (FNAC). The
absolute sensitivity of FNAC when biopsying microcalcifi-
cation can be as high as 71% [15]. In general, however,
the absolute sensitivity of FNAC in diagnosing DCIS is
only in the region of 53% [16]. Although the lower
absolute sensitivity of FNAC in the diagnosis of DCIS is of
concern, the major issue when using FNAC in the diagno-
sis of microcalcification is the unreliability of FNAC to
make a definitive diagnosis of benignity. In a series from
Guildford, UK [15], 36% of indeterminate calcifications
with C1 or C2 cytology were malignant. Stereotactically
guided core biopsy of indeterminate calcification allows
accurate diagnosis of the majority of microcalcification
clusters. The ability to perform specimen radiography to
confirm the presence of representative calcification within
the specimens represents a significant advantage over fine-
needle aspiration. The more recent widespread use of
digital imaging has further enhanced the ability of stereo-
tactic core biopsy to diagnose microcalcification accurately.
The introduction of digital stereotaxis has enabled the use
of many more check pairs during a biopsy procedure. This
allows very precise placement of the needle before firing
and shortens the interval between obtaining an adequate
position and firing; thus, the patient has less time to move
out of position. With the introduction of digital stereotaxis
our calcification retrieval rate immediately rose from 55%
to 85%. Our absolute sensitivity for the diagnosis of pure
DCIS rose from 34% to 69% and the complete sensitivity
from 52% to 94% [13]. With further experience in the use
of digital stereotaxis, our calcification retrieval rate for
microcalcific lesions is now 96% and our absolute sensi-
tivity for diagnosing pure DCIS is 81%. These figures indi-
cate that the results of upright digital stereotaxis are
similar to those achieved with prone table stereotactic
biopsies. Acquiring specimen radiographs promptly is
important when performing stereotactic core biopsies of
microcalcifications. The use of digital imaging to provide
immediate specimen radiography is very helpful because
there is no delay between performing the biopsy and
knowing whether the biopsy has been successful. It also
means that if the specimen radiograph is negative then
further cores can be taken without delay.
There is increasing absolute and complete sensitivity
(absolute sensitivity is the percentage of B5 results from a
malignant lesion, whereas complete sensitivity counts B3,
B4 and B5 results as positive) with increasing number of
cores, with six or more cores giving a better diagnostic
yield than five cores [17]. These results highlight the
frequent need to take multiple cores, and certainly 10–15
cores of microcalcification is not excessive. A recent study
[18] aimed to determine whether the number of flecks of
calcification retrieved with stereotactic needle core or the
numbers of cores containing calcification were related to
biopsy sensitivity. The investigators found that 100% com-
plete sensitivity was obtained once three individual calcific
flecks were obtained, but for 100% absolute sensitivity
five or more flecks of calcification were required on speci-
men radiography. That study also showed that two of the
cores showing at least one fleck of calcification was
required for 100% complete sensitivity. For 100%
absolute sensitivity, three separate cores each containing
at least one fleck were required at specimen radiography.
The other important finding of the study was that three
specimen radiographs that contained only one or two
flecks of calcification gave a benign result, even though
the lesion was malignant on excision.
It has become clear that there are a number of cases in
which image guided core biopsy significantly ‘under-
stages’ malignant microcalcification. Most series indicate
that approximately 50% of lesions with ADH on core show
either DCIS or DCIS with invasive cancer at surgical
excision [19]. Multiple studies have shown that approxi-
mately 20% of lesions giving a core biopsy result of DCIS
have invasive disease at excision biopsy [20].
Percutaneous biopsy devices are now available that
provide much larger volumes of tissue, and these can be
used to reduce the need for diagnostic open surgical
biopsy for benign conditions and to provide higher rates of
preoperative diagnosis for malignant disease. Vacuum
assisted mammotomy (VAM) retrieves multiple contiguous
14, 11 or 8 French gauge core samples by combining
core biopsy with a vacuum system for both acquiring and
retrieving tissue samples. VAM will under-stage disease
less than half as often as will conventional core biopsy.
The difference is particularly marked in the under-staging
of DCIS. In a large review of core and VAM needle biop-
sies, DCIS was found at surgery following a biopsy result
of ADH in 41% of core biopsies and only 15% of vacuum
assisted samples. VAM underestimates the presence of
invasive malignancy associated with DCIS in only 11%. A
similar study found that VAM underestimated the pres-253
ence of invasive disease in half as many patients with
DCIS as did core biopsy (10% versus 21%) and under-
staged DCIS in 19% as compared with 40% [21–23].
A number of studies have shown DCIS and invasive carci-
noma following excision of lesions yielding ALH and LCIS
at percutaneous biopsy [24–26]. The risk appears to be
lowest for ALH and highest for pleomorphic LCIS with
central necrosis and in lesions in which residual calcifica-
tions remain in situ. The majority of authors advise excision
of calcific lesions with a core biopsy result of pleomorphic
LCIS.
Conclusion
In conclusion, the detection, assessment and biopsy of
DCIS remains a challenge but the benefits of detecting
high grade DCIS and associated small invasive foci make
it a worthwhile task.
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This article is the first in a review series on 
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